KyFect™ - AAV Transfection Reagent (14570)
KyFect™ - AAV Transfection Reagent (14570)
KyFect™ - AAV Transfection Reagent (14570)
Roll over image to zoom in Click on image to zoom
KyFect™ - AAV Transfection Reagent (14570)KyFect™ - AAV Transfection Reagent (14570)KyFect™ - AAV Transfection Reagent (14570)
Download Product Brochure

KyFect™ - AAV Transfection Reagent (14570)

No reviews

- High AAV titers every time
- Scalability from flask to bioreactor
- Cost-efficiency without compromise

SKU Size: 14570-1 (1mL)
Contact Us for Pricing

Introducing KyFect™ - AAV: a next-generation transfection reagent engineered for adeno-associated virus (AAV) production. Built for flexibility and scale, it enables efficient plasmid delivery, high-yield viral titers, and reproducible performance from early-stage discovery through upstream process development. Fully synthetic and manufactured entirely in-house in Pennsylvania, KyFect™ - AAV offers reliable supply, reduced lead times, and complete quality control. Whether you're optimizing your workflow or ramping up production, KyFect™ - AAV empowers you to accelerate progress with greater speed and efficiency.

Store At Temperature 2 - 8°C
Shipping Condition Cold Pack

High AAV titers, every time

  • Consistently efficient plasmid transfection resulting in 2x viral titers versus market alternates.

Scalability from flask to bioreactor

  • Reliable performance across formats, from small-scale shake flasks to large-scale bioreactors.

Unmatched flexibility

  • Supports a range of AAV serotypes, DNA concentrations and ratios, complexation times, as well as adherent and suspension HEK293-based production platforms. 

Cost-Efficiency Without Compromise

  • Reduce plasmid usage, increase productivity, and lower cost per dose—without sacrificing performance.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.

GMP Grade Coming Soon

  • Seamless transition from process development to commercialization.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

Introducing KyFect™ - AAV: a next-generation transfection reagent engineered for adeno-associated virus (AAV) production. Built for flexibility and scale, it enables efficient plasmid delivery, high-yield viral titers, and reproducible performance from early-stage discovery through upstream process development. Fully synthetic and manufactured entirely in-house in Pennsylvania, KyFect™ - AAV offers reliable supply, reduced lead times, and complete quality control. Whether you're optimizing your workflow or ramping up production, KyFect™ - AAV empowers you to accelerate progress with greater speed and efficiency.

Store At Temperature 2 - 8°C
Shipping Condition Cold Pack

High AAV titers, every time

  • Consistently efficient plasmid transfection resulting in 2x viral titers versus market alternates.

Scalability from flask to bioreactor

  • Reliable performance across formats, from small-scale shake flasks to large-scale bioreactors.

Unmatched flexibility

  • Supports a range of AAV serotypes, DNA concentrations and ratios, complexation times, as well as adherent and suspension HEK293-based production platforms. 

Cost-Efficiency Without Compromise

  • Reduce plasmid usage, increase productivity, and lower cost per dose—without sacrificing performance.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.

GMP Grade Coming Soon

  • Seamless transition from process development to commercialization.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

Any questions?

If we still haven't answered your question, you can contact us below and we will get back to you as soon as possible.
Customer support
1-866-992-4418

For technical inquiries contact techsupport@kyfora.com,

For pricing and general questions contact info@kyfora.com

You may also like

Recently viewed